ERFSF (Eurofins Scientific SE) EPS without NRI: $4.51 (TTM As of Dec. 2025)


ERFSF Eurofins Scientific SE ERFSF
77 GF Score
Price $79.77
GF Value $77.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE EPS without NRI?

Eurofins Scientific SE ERFSF +3.01% 77 EPS without NRI is $4.51 as of Dec. 2025. GuruFocus rates ERFSF with a GF Score™ of 77/100 and a GF Value™ of $77.44 (Fairly Valued). The stock has 7 warning signs investors should review. Among 161 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks worse than 57.14% on this metric.

Eurofins Scientific SE's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $2.31. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $4.51.

During the past 12 months, Eurofins Scientific SE's average earnings per share (NRI) Growth Rate was 9.90% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 5.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -1.80% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Eurofins Scientific SE's EPS without NRI or its related term are showing as below:

ERFSF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -11.2   Med: 24.5   Max: 341.4
Current: 5.4

During the past 13 years, Eurofins Scientific SE's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 341.40% per year. The lowest was -11.20% per year. And the median was 24.50% per year.

ERFSF's 3-Year EPS without NRI Growth Rate is ranked worse than
57.14% of 161 companies
in the Medical Diagnostics & Research industry
Industry Median: 10.8 vs ERFSF: 5.40

Eurofins Scientific SE's EPS (Diluted) for the six months ended in Dec. 2025 was $1.45. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $2.96.

Eurofins Scientific SE's EPS (Basic) for the six months ended in Dec. 2025 was $1.51. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $3.07.


Eurofins Scientific SE  (OTCPK:ERFSF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Eurofins Scientific SE EPS without NRI Related Terms


Eurofins Scientific SE EPS without NRI Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE EPS without NRI Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.70 3.51 3.14 3.70 4.54

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 1.77 1.98 2.20 2.31

ERFSF vs TMO, DHR, IDXX: EPS without NRI Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's PE Ratio without NRI falls into.


ERFSF
77GF Score
Eurofins Scientific SE ERFSF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $4.51 mean?
Eurofins Scientific SE (ERFSF) has a EPS without NRI of $4.51 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Eurofins Scientific SE and its competitors. According to the industry distribution chart, Eurofins Scientific SE ranks #92 out of 161 companies in the Medical Diagnostics & Research industry, placing it in the top 57.1%.
Is Eurofins Scientific SE's EPS without NRI too high?
Eurofins Scientific SE's current EPS without NRI is $4.51. The Medical Diagnostics & Research industry median EPS without NRI is 10.80. Eurofins Scientific SE's value of $4.51 is 58.2% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #92 out of 161 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #92 out of 161 companies for EPS without NRI. This places Eurofins Scientific SE in the lower half of its industry. The industry median EPS without NRI is 10.80. Eurofins Scientific SE's value of $4.51 is 58.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.80, based on 161 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current EPS without NRI of $4.51 is 58.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current EPS without NRI is $4.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $77.44, compared to a current price of $79.77 — trading 3% above its estimated fair value. The current EPS without NRI is $4.51 and 58.2% below the Medical Diagnostics & Research industry median of 10.80. Eurofins Scientific SE's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current EPS without NRI is $4.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of $79.77 is trading 3% above its estimated GF Value™ of $77.44. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • EPS without NRI: $4.51
  • GF Value™: $77.44 vs. price of $79.77 (3% above fair value)
  • GF Score™: 77/100 with 7 warning signs
  • Industry Position: 58.2% below the Medical Diagnostics & Research median (#92 of 161)

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
77GF Score

Get the complete analysis for ERFSF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.77
Price
$77.44
GF Value